Staphylococcus aureus is
considered
as one of the most widespread bacterial pathogens and continues to
be a prevalent cause of mortality and morbidity across the globe.
FmtA is a key factor linked with methicillin resistance in S. aureus. Consequently, new antibacterial compounds
are crucial to combat S. aureus resistance.
Here, we present the virtual screening of a set of compounds against
the available crystal structure of FmtA. The findings indicate that
gemifloxacin, paromomycin, streptomycin, and tobramycin were the top-ranked
potential drug molecules based on the binding affinity. Furthermore,
these drug molecules were analyzed with molecular dynamics simulations,
which showed that the identified molecules formed highly stable FmtA–inhibitor(s)
complexes. Molecular mechanics Poisson–Boltzmann surface area
and quantum mechanics/molecular mechanics calculations suggested that
the active site residues (Ser127, Lys130, Tyr211, and Asp213) of FmtA
are crucial for the interaction with the inhibitor(s) to form stable
protein–inhibitor(s) complexes. Moreover, fluorescence- and
isothermal calorimetry-based binding studies showed that all the molecules
possess dissociation constant values in the micromolar scale, revealing
a strong binding affinity with FmtAΔ80, leading to
stable protein–drug(s) complexes. The findings of this study
present potential beginning points for the rational development of
advanced, safe, and efficacious antibacterial agents targeting FmtA.